Recent data from the online appointment platform Zocdoc reveal a striking shift in how patients interact with their health‑care providers after beginning GLP‑1 therapy. Those who book an initial GLP‑1 consultation are 21% more likely to schedule additional medical visits over the next 12 months than the average Zocdoc user.
More Visits, More Engagement
According to the platform, 42.6% of patients who first saw a provider for a GLP‑1 prescription also booked a primary‑care appointment within the following year—more than double the rate for typical users. This pattern suggests that the medication is acting as a catalyst, encouraging patients to re‑engage with their overall health care.
Physician Perspective
“GLP‑1s have finally given people real, tangible success,” said Dr. Amy Sheer, an obesity‑medicine specialist and associate professor of medicine at the University of Florida. “I’ve seen people completely change their health and their lives in ways we weren’t seeing before.” Dr. Sheer emphasizes that GLP‑1 prescriptions are not a “set‑it‑and‑forget‑it” solution; they require ongoing monitoring, dose adjustments, and management of side effects.
Managing Early Side Effects
Because GLP‑1 drugs slow gastric emptying, many patients experience nausea, acid reflux, constipation, or diarrhea when they first start treatment. An Australian study cited in the article found that nearly 43% of new GLP‑1 users without prior symptom‑relief medication needed a secondary prescription to address these issues. Importantly, these additional prescriptions did not increase emergency‑room visits or hospitalizations, indicating that side effects can be effectively managed in routine outpatient settings.
Comprehensive Care Teams
Clinicians are using the early treatment window to build multidisciplinary support. Dr. Jonathan Bonnet, chief medical officer at the Ardmore Institute of Health, explains that patients often require adjustments to existing medications for blood pressure, diabetes, or cholesterol as they lose weight. “When you’re taking one of these, you actually have to eat better than when you’re not,” he notes, highlighting the need for dietitian, physical‑therapy, and mental‑health resources.
Patients like Elissa Drassinower, who has been on a GLP‑1 for four years and lost more than 50 pounds, report that the medication has deepened their relationship with their doctors. “I’m lucky that my doctor is very accessible through the portal,” she said, noting that quick answers to questions have fostered greater trust.
Long‑Term Commitment
Experts caution that GLP‑1 therapy is typically an ongoing commitment rather than a short‑term fix. Data show that weight tends to return when treatment stops, so sustained prescribing and regular follow‑up are essential. Dr. Bonnet adds that proactive deprescribing—reducing or stopping other medications as patients improve—helps prevent over‑medication.
Patient‑Driven Lifestyle Changes
Beyond weight loss, many patients report paying closer attention to other health areas. Joe Coe, a year‑long GLP‑1 user, says losing weight prompted him to take his migraines more seriously and address other symptoms that interfered with exercise. “If you want to maintain a level of activity to keep the weight off, you need to be healthy in these other aspects of your life,” he explained.
Overall, the Zocdoc findings suggest that GLP‑1 medications are reshaping the traditional episodic doctor‑visit model into a more continuous partnership, with patients returning for primary‑care, specialty, mental‑health, and wellness appointments. As clinicians adapt to this new dynamic, they stress the importance of accessible communication, multidisciplinary support, and a patient‑centered approach to sustain the health gains achieved through GLP‑1 therapy.
Original reporting: KRDO (Colorado Springs metro) — read the source article.
